Adjustable radiation source

Information

  • Patent Grant
  • 6352501
  • Patent Number
    6,352,501
  • Date Filed
    Thursday, September 23, 1999
    25 years ago
  • Date Issued
    Tuesday, March 5, 2002
    23 years ago
Abstract
An intravascular medical device including an elongate shaft and a variable-length ionizing radiation source disposed on the distal end thereof. The present invention may be manifested as a source wire, a guide wire, a catheter or other suitable intravascular device with an adjustable length radiation source. For example, the adjustable source may be implemented on a wire having a variable-length radioactive tip, on a balloon catheter having a variable-length balloon inflated with a radioactive fluid, or on a catheter having means for advancing and retracting radioactive seeds of variable number and/or spacing.
Description




FIELD OF THE INVENTION




The present invention generally relates to medical devices. More specifically, the present invention relates to medical devices suitable for intravascular ionizing radiation therapy.




BACKGROUND OF THE INVENTION




Intravascular ionizing radiation therapy is being used increasingly to treat vascular disease. For example, intravascular ionizing radiation therapy has been proposed as both a primary and a secondary therapy for treating vascular restrictions. Clinical studies have shown that ionizing radiation may be used to inhibit or prevent restenosis after percutaneous transluminal angioplasty (PTA). In coronary applications, such vascular restrictions may range in length from a few millimeters to several centimeters, depending on the extent and nature of the disease, in addition to the size and type of vessel affected.




Typically, physicians evaluate the size (length and diameter) and nature of the vascular restriction in order to determine the appropriate treatment length and the corresponding ionizing radiation device to be used for treatment. However, intravascular ionizing radiation devices commonly utilize a fixed-length radiation source, and the number of different sizes available is limited. Accordingly, in some instances, the physician is not be able to select the correct radiation source length. Such limitations may leave the physician with no alternative but to select an intravascular ionizing radiation device having an improper radiation source length.




Thus, when utilizing an ionizing radiation device having a fixed-length radiation source disposed on the distal end thereof, clinical circumstances often give rise to a mismatch between the length of the radiation source and the length of the treatment site. Specifically, the length of the radiation source may be too long or too short as compared to the length of the treatment site. If the radiation source is too long, healthy tissue disposed at either end of the treatment site will inevitably be exposed to ionizing radiation. Exposing healthy tissue to ionizing radiation is clearly an undesirable event.




If the radiation source is too short, it is necessary to reposition the fixed-length radiation source in the vessel. Unless the treatment site is an exact whole number multiple of the length of the radiation source and the radiation source is precisely repositioned, various areas of the treatment site will inevitably have more or less radiation exposure than other areas of the treatment site. Repositioning the radiation source may result in overlapping exposure or healthy tissue exposure. Even if the treatment site length is an exact whole number multiple of the length of the radiation source, repositioning of a relatively short radiation source may be inherently imprecise and may require an increase in dwell time, both of which are not desirable. As a result, it is common for various regions of the treatment site to be either underexposed or overexposed to ionizing radiation due to a mismatch in length between the treatment site and the radiation source.




An example of a clinical implication of selecting an ionizing radiation device having an improper radiation source length has been observed, and is commonly referred to as the “candy wrapper” effect. The “candy wrapper” effect occurs when the length of the radiation source does not entirely cover the desired treatment site, thus, potentially leaving opposite ends of the vascular restriction untreated. The untreated regions of the vascular restriction may tend to restenos or re-occlude over time. The “candy wrapper” effect may be compounded when a beta radiation source is used, due to the shorter depth penetration of beta radiation. As such, the conventional practice is to expose the treatment site to ionizing radiation beyond the proximal and distal ends of the restriction to avoid the “candy wrapper” effect. However, such practice may expose otherwise healthy vascular tissue to potentially harmful ionizing radiation.




To address the issue of mismatched treatment length and radiation source length, ionizing radiation devices that utilize a moveable shield have been proposed. For example, U.S. Pat. No. 5,213,561 to Weinstein et al. discloses a device for preventing restenosis after angioplasty, wherein the device includes a radioactive source and a moveable shield in the form of an longitudinally shiftable sleeve to selectively expose the radioactive source. Shielded devices such as this allow adjustments to be made during the procedure in order to change the length of the exposure. Unfortunately, however, such fixed-length shielded devices tend to be stiff and relatively large, making it difficult to position the shielded portion of the device in tortuous or small diameter vasculature.




SUMMARY OF THE INVENTION




The present invention overcomes these disadvantages by providing an intravascular medical device including an elongate shaft and a variable-length ionizing radiation source disposed on the distal end thereof. The present invention may comprise a source wire, a guide wire, a catheter or other suitable intravascular device with an adjustable length radiation source. In one embodiment, the adjustable source is implemented on a wire having a variable-length radioactive tip. In another embodiment, the adjustable source is implemented on a balloon catheter having a variable-length balloon inflated with a radioactive fluid. In yet another embodiment, the adjustable source is implemented on a catheter having means for advancing and retracting radioactive seeds of variable number and/or spacing.




The intravascular device of the present invention provides a variable-length radiation source to compensate for any mismatch in length that would otherwise occur between a fixed-length radiation source and the treatment site. Thus, the variable-length design of the present invention improves the match between the radiation source length and the treatment site length. In addition, the variable-length design of the present invention reduces the inventory that must be kept on hand to treat different patients with different treatment site lengths, thereby reducing the otherwise significant cost of storing radioactive material. As compared to fixed-length devices of the prior art that require a shield to vary radiation exposure, the variable-length design of the present invention provides a more flexible and lower profile device by eliminating the need for a shield.




As implemented on a wire having a variable-length radioactive tip, the tip may comprise a coil, a braid, an elastomeric tube, or other suitable structure capable of longitudinal expansion and contraction. The radiation source may be formed of radioactive material, or the radiation source may be formed of an inert base material with a radioactive coating, dispersion, impregnation, composite, etc., thereon or therein. To affect variations in length of the source, the elongate shaft may include an outer tube and a movable core wire disposed therein. In this embodiment, the proximal end of the radiation source is connected to the distal end of the outer tube, and the distal end of the radiation source is connected to the distal end of the core wire. With this arrangement, longitudinal displacement of the core wire relative to the outer tube causes corresponding longitudinal displacement of the distal end of the radiation source, which in turn causes longitudinal expansion or contraction of the radiation source. Thus, both the length of the ionizing radiation source and the radioactivity per unit length may be varied.




As implemented on a balloon catheter having a variable-length balloon inflated with a radioactive fluid, the length of the balloon may be varied by a number of different means. For example, the length of the balloon may be varied by selectively retracting a constraining sleeve disposed about the balloon. Alternatively, the length of the balloon may be varied by utilizing an inverting balloon and selectively extending one end of the balloon. Any desired radioactive fluid and/or suspension may be used in conjunction with the variable-length balloon.




As implemented on a catheter having means for advancing and retracting radioactive seeds, either the number, spacing or both may be varied to effectively control the length of the radiation source. The seeds or pellets may be advanced and retracted by pneumatic means or by mechanical means.











BRIEF DESCRIPTION OF THE DRAWINGS





FIGS. 1A and 1B

are longitudinal cross-sectional views of the present invention in the form of an elongate wire having a variable-length radioactive tip.

FIG. 1A

shows the variable-length tip in the contracted (i.e., short) state, and

FIG. 1B

shows the variable-length tip in the extended (i.e., long) state;





FIGS. 2A and 2B

are detailed longitudinal cross-sectional views of the elongate wire shown in

FIGS. 1A and 1B

, respectively;





FIGS. 3

,


4


and


5


are lateral cross sectional views taken along lines


3





3


,


4





4


and


5





5


, respectively, in

FIG. 2A

;





FIGS. 6A and 6B

are longitudinal cross-sectional views of the present invention in the form of a balloon catheter having a variable-length balloon filled with radioactive fluid.

FIG. 6A

shows the variable-length balloon in the unrestrained position, and

FIG. 6B

shows the variable-length balloon in the restrained position;





FIGS. 7A and 7B

are longitudinal cross-sectional views of the present invention in the form of an alternative balloon catheter having a variable-length inverted balloon filled with radioactive fluid.

FIG. 7A

shows the variable-length balloon in the extended position, and

FIG. 7B

shows the variable-length balloon in the contracted position;





FIGS. 8A and 8B

are longitudinal cross-sectional views of the present invention in the form of a catheter having means for advancing and retracting radioactive seeds of variable number.

FIG. 8A

shows the catheter having several seeds disposed in the distal end thereof to define a long radioactive section, and

FIG. 8B

shows fewer seeds to define a short radioactive section; and





FIGS. 9A and 9B

are longitudinal cross-sectional views of the present invention in the form of a catheter having means for advancing and retracting radioactive seeds of variable spacing.

FIG. 9A

shows the catheter having several spacers between the seeds to define a long radioactive section, and

FIG. 9B

shows fewer spacers between the seeds to define a short radioactive section.











DETAILED DESCRIPTION OF THE INVENTION




The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.




Refer to

FIGS. 1A and 1B

, which illustrate longitudinal cross-sectional views of the medical device of the present invention in the form of an elongate wire


10


. Although illustrated as a wire


10


, the medical device of the present invention may be manifested in a wide variety of forms. For example, the medical device of the present invention may take the form of a guide wire, a source wire, a centering device, a simple tubular catheter, a balloon catheter, or other suitable intravascular device. For purposes of illustration only, the present invention has been described with reference to a wire


10


having an extendable radioactive tip (FIGS.


1


A-


5


), catheters


40


/


60


having a variable-length balloon filled with radioactive fluid (FIGS.


6


A-


7


B), and a catheter


80


having means for advancing and retracting radioactive seeds of variable number and/or spacing (FIGS.


8


A-


9


B).




Regardless of the specific embodiment, the medical device of the present invention includes an elongate shaft suitable for intravascular navigation and a variable-length ionizing radiation source disposed on the distal end thereof. In addition, regardless of the specific embodiment, the medical device of the present invention includes a means to vary the length of the radiation source. For example, in the elongate wire


10


embodiment illustrated in

FIGS. 1A and 1B

, the wire


10


a variable-length ionizing radiation source or extendable tip


14


disposed on the distal end of a shaft


12


. Also in this embodiment, the means for varying the length of the tip


14


comprises an outer tubular member


20


having a moveable core


22


disposed therein.




The means by which the length of the extendable tip


14


is varied may comprise a moveable core


22


disposed in an outer tubular member


20


as illustrated, but may also comprise a wide variety of other suitable mechanisms. The primary objective of a suitable mechanism is to cause longitudinal displacement of the distal end of the tip


14


relative to the proximal end of the tip


14


. Such longitudinal displacement thereby causes corresponding longitudinal contraction or expansion of the tip


14


. With this objective in mind, those skilled in the art will readily appreciate that other suitable mechanisms may be employed.




For example, two elongate members disposed side-by-side may be connected to opposite ends of the extendable tip


14


, wherein the elongate members may be longitudinally displaced relative to each other to affect changes in length of the tip


14


. Alternatively, similar to the embodiment illustrated, two tubular elongate members co-longitudinally disposed may be connected to opposite ends of the tip


14


. Skilled artisans will recognize that these and many other mechanical linkages may be employed to affect changes in length of the tip


14


.




As an alternative to mechanical linkages, longitudinal contraction or expansion of the tip


14


may be accomplished by pneumatic mechanisms. For example, a proximal end of the tip


14


may be connected to a hollow cylinder, with the distal end of the tip


14


connected to a piston disposed in the hollow cylinder. Fluid pressure may be delivered to the hollow cylinder by a variety of means in order to pneumatically control longitudinal displacement of the piston disposed therein. With this arrangement, longitudinal contraction or expansion of the tip


14


may be affected by changing the pressure delivered to the hollow cylinder. Those skilled in the art will recognize that these examples are merely illustrative, as a wide variety of means, including mechanical and pneumatic means, may be employed without departing from the scope or spirit of the invention.




Referring to the particular embodiment illustrated in

FIGS. 1A and 1B

, the proximal end of the extendable tip


14


is connected to the distal end


24


of the outer tubular member


20


. The distal end of the tip


14


is connected to the distal end of the core member


22


. With this arrangement, longitudinal displacement of the distal end


26


of the core member


22


relative to the distal end


24


of the outer tubular member


20


causes corresponding longitudinal displacement of the distal end of the tip


14


. Longitudinal contraction or expansion, in turn, is caused by longitudinal displacement of the distal end of the tip


14


.




Specifically, moveable core member


22


may be retracted in the proximal direction relative to shaft


12


as indicated by arrow


16


to cause the variable-length tip


14


to longitudinally contract to a length L


1


as illustrated in FIG.


1


B. In addition, core member


22


may be advanced in the distal direction relative to shaft


12


as indicated by arrow


18


to cause longitudinal expansion of the variable-length tip


14


to a second length L


2


as illustrated in FIG.


1


B. With this arrangement, the length of the tip


14


may be varied from an longitudinally contracted length L


1


to an longitudinally expanded length L


2


, where L


2


is greater than L


1


, by actuating the core member


22


relative to the outer tubular member


20


as indicated by arrows


16


and


18


. The core member


22


may be manually actuated relative to the outer tubular member


20


by the treating physician. Alternatively, a pneumatic or mechanical actuator may be used to displace the core member


22


relative to the outer tubular member


20


. Such an actuator may be disposed in the afterloader.




The extendable tip


14


may comprise a coil


28


as shown or may comprise a variety of other structures capable of longitudinal contraction and expansion. For example, the tip


14


may comprise a braid or an elastomeric tube. For purposes of illustration only, the tip


14


has been shown in the form of a coil. Tip


14


may be formed of a radioactive material or may be formed of an inert base material having a radioactive material disposed thereon or therein. For example, a base material of stainless steel may be utilized with a radioactive material comprising P32 plated thereon. If the tip


14


is in the form of an elastomeric tube, the radioactive material may comprise small particles dispersed in the wall of the polymer tube. Suitable base materials for a coil or braid structure include stainless steel, gold, and platinum. Preferably, the base material comprises a radiopaque material to facilitate radiographic visualization and navigation with the assistance of fluoroscopy. In the case of an elastomeric tube, suitable base materials include silicone, polyurethane, or other biocompatible elastomeric polymers. Suitable radioactive materials include W188, Sr90, Ru106, Y90, Ir192 and P32. The particular form of the tip


14


and the particular base and radioactive materials of the tip


14


are not particularly critical as long as the tip


14


is variable-length and functional in the vasculature.




The variable-length tip


14


preferably has a uniform radioactivity, aside from natural decay. With a constant radioactivity, variations in length of the tip


14


cause corresponding variations in radioactivity per unit length. As compared to a conventional shielded fixed-length radiation source, the total radiation dose delivered to the treatment site with the present invention does not vary with the length of the radiation source exposed. Limiting the total radiation dose independent of length may be clinically important to avoid adverse effects of overexposure to ionizing radiation.




Refer now to

FIGS. 2A and 2B

which illustrate detailed longitudinal cross-sectional views of the elongate wire


10


shown in

FIGS. 1A and 1B

, respectively. Elongate shaft


12


includes an outer tubular member


20


and a moveable core member


22


disposed therein. Moveable core member


22


may include a proximal stop


32


to limit longitudinal displacement of the core member


22


relative to the outer tubular member


20


, thereby limiting longitudinal expansion of the tip


14


. The elongate shaft


12


may have an outside diameter on the order of 0.010-0.040 inches and a length on the order of 150-350 cm to facilitate navigation through human vasculature, including the coronary vasculature. The elongate shaft


12


may be formed of virtually any suitable medical grade metal or polymer, but preferably the outer tubular member


20


is formed of a super-elastic alloy such as nickel titanium, and moveable core member


22


is formed of stainless steel. Those skilled in the art will recognize that the materials and dimensions of the elongate shaft


12


may be varied depending on the particular vascular anatomy being navigated.




As mentioned previously, the proximal end of the tip


14


is secured to the distal end


24


of the outer tubular member


20


. Similarly, the distal end of the tip


14


is connected to the distal end


26


of the moveable core member


22


. If a metal coil


28


is utilized for the tip


14


as illustrated, and if a metallic core member


22


is utilized, the distal end of the coil


28


may be welded to the distal end of the moveable core member


22


to form an a traumatic weld ball


26


. Similarly, if a metallic outer tubular member


20


is utilized, the proximal end of the coil


28


may be connected to the distal end


24


of the outer tubular member


20


utilizing a solder joint


30


. If dissimilar materials are used as between the tip


14


and the distal ends


24


and


26


, a suitable medical grade adhesive may be used to make the connections.




Refer now to

FIGS. 3

,


4


and


5


, which illustrate lateral cross-sectional views taken along lines


3





3


,


4





4


and


5





5


, respectively, in FIG.


2


A. As can be seen in

FIGS. 3 and 4

, a gap


34


is provided between the moveable core member


22


and the outer tubular member


20


to minimize the friction therebetween. As can be seen in

FIG. 5

, a relatively small gap is formed between the moveable core member


22


and the distal end


24


of the outer tubular member


20


. In particular, the distal end


24


of the outer tubular member


20


is tapered to reduce the outside and inside diameters. Reduction of the outside diameter facilitates connection to the proximal end of the tip


14


without increasing the profile at the juncture. Reduction of the inside diameter facilitates minimizing lateral displacement of the moveable core


22


as it moves therethrough.




In use, the elongate wire


10


embodiment may be used in conjunction with an afterloader and a centering device, both of which are well known in the art. If desired, the treatment site may be pre-dilated utilizing a balloon angioplasty catheter, an atherectomy catheter or other suitable PTCA device. Typically, a centering device, such as a balloon catheter with a segmented or helical balloon disposed at the distal end thereof, is navigated to the desired treatment site using a guide wire and conventional fluoroscopic techniques. Once the centering device is positioned adjacent the treatment site and inflated, the elongate radiation source wire


10


may be advanced through the centering device utilizing an afterloader. The afterloader may also be used to affect the change in length of the radiation source. Preferably prior to advancing the source wire


10


, the length of the tip


14


may be adjusted to correspond to the length of the treatment site. However, the length of the tip


14


may be varied during the procedure if desired. After sufficient dwell time (i.e., the time the tip


14


is positioned adjacent the treatment site), the elongate wire


10


may be withdrawn from the centering catheter utilizing the afterloader. Because the total radioactivity of the tip


14


remains constant and the radioactivity per unit length varies with changes in length, the dwell time may be adjusted to provide the desired dose to the particular treatment site. After or simultaneously with removal of the elongate wire


10


, the centering device and all ancillary devices may then be removed, marking the completion of the procedure.




Refer now to

FIGS. 6A and 6B

which illustrate longitudinal cross-sectional views of the present invention in the form of a balloon catheter


40


, having a variable length balloon


50


filled with a radioactive fluid. Balloon catheter


40


is similar to wire


10


in form and function except as described herein. Catheter


40


represents a generic catheter having a variable balloon for which there are a number of suitable specific embodiments. For example, suitable specific embodiments are disclosed in U.S. Pat. No. 4,564,014 to Fogarty et al., U.S. Pat. No. 5,246,421 to Saab, and co-pending patent application Ser. No. 08/950,520 now U.S. Pat. No. 5,961,536 to Mickley et al., each of which are fully incorporated herein by reference. For purposes of simplicity and clarity, only the distal portion of the catheter


40


has been illustrated in generic form.




Catheter


40


includes an outer sheath


42


slidably disposed about an inner catheter shaft


44


. Inner catheter shaft


44


may include an outer tube


46


and an inner tube


48


co-axially disposed therein. An inflatable balloon is connected to the distal end of the inner catheter shaft


44


. Specifically, the proximal end of the balloon


50


is connected to the distal end of the outer tube


46


, and the distal end of the balloon


50


is connected to the distal end of the inner tube


48


. Inner tube


48


defines a guide wire lumen


58


through which a conventional guide wire may be inserted. An inflation lumen


56


is defined by the annular space between the outer tubular member


46


and the inner tubular member


48


. Inflation lumen


56


is in fluid communication with the interior


54


of the balloon


50


such that the balloon


50


may be inflated and deflated with a radioactive fluid. Such radioactive fluid may comprise a liquid having a radioactive isotope suspended therein. Other suitable radioactive fluids are known in the art.




As shown in

FIG. 6A

, outer sheath


42


may be retracted proximal of the balloon


50


expands unconstrained to its nominal length and diameter. Under this condition, the radioactive fluid disposed in the interior


54


of the balloon


50


provides a treatment length of approximately L


1


. As shown in

FIG. 6



b,


outer sheath


42


may be longitudinally displaced in the distal direction as indicated by arrow


52


to radially constrain expansion of the balloon


50


. With the outer sheath


42


so positioned, the balloon


50


defines a constrained portion and an expanded portion of the balloon


50


as an interior


54


filled with radioactive fluid to provide a treatment length of approximately L


2


. Accordingly, longitudinal displacement of the outer sheath


42


relative to the inner catheter shaft


44


and the balloon


50


causing the balloon


50


to change in length. Changes in length of the balloon


50


correspondingly changes the size of the expanded portion of the balloon and thus the size of the interior of the balloon containing radioactive fluid. In this manner, the outer sheath


42


may be longitudinally displaced to control the effective treatment length of the radioactive fluid contained in the interior


54


of the balloon


50


.




Examples of catheters having inflatable balloons containing radioactive fluid may be found in U.S. Pat. No. 5,616,114 to Thornton et al., International Patent Application Publication No. WO 97/40889 to Apple et al., and U.S. patent application Ser. No. 08/154,267 now U.S. Pat. No. 5,596,099 to Sahatjian, the entire disclosures of which are hereby incorporated by reference. In light of these disclosures, only the distal portion of the catheter


40


has been illustrated for purposes of clarity and simplicity.




Catheter


40


may be used substantially the same as described in U.S. Pat. No. 5,616,114 to Thornton et al., except that the length of the radiation source (i.e., balloon


50


) may be adjusted by longitudinal displacement of the outer sheath


42


as described above.




Refer now to

FIGS. 7A and 7B

which illustrate longitudinal cross-sectional views of the present invention in the form of an alternative balloon catheter


60


having a variable length inverted balloon


68


. Catheter


60


is substantially the same as catheter


40


in both form and function, except as described herein. Catheter


60


represents a generic catheter having a variable length inverted balloon for which there are several corresponding specific embodiments. For example, U.S. Pat. No. 5,163,927 to Woker et al. and U.S. Pat. No. 5,171,305 to Schickling et al., both of which are hereby incorporated by reference, disclose specific embodiments of a catheter having an inverted balloon. In light of these disclosures, and the disclosure of U.S. Pat. No. 5,616,114 to Thornton et al., only the distal portion of the catheter


60


is illustrated for purposes of simplicity and clarity.




Catheter


60


includes an elongate shaft


62


having an outer tubular member


64


and inner tubular member


66


co-axially disposed therein. An inverting balloon


68


is connected to the distal end of the elongate shaft


62


. Specifically, the proximal end of the inverting balloon


68


is connected to the distal end of the outer tubular member


64


, and the distal end of the inverting balloon


68


is connected to the distal end of the inner tubular member


66


. A guide wire lumen


74


is defined by the inner tubular member


66


and is adapted for insertion of a guide wire therein. An inflation lumen


72


is defined in the annular space between the outer tubular member


64


and the inner tubular member


66


. Inflation lumen


72


is in fluid communication with the interior


70


of the balloon


68


, which is filled with a radioactive fluid with inflated.





FIG. 7



a


illustrates the balloon


68


and the fully extended and inflated state wherein the interior


70


of the balloon contains a radioactive fluid to define a radioactive source having an approximate length of L


1


. As illustrated in

FIG. 7



b,


the inner tubular member


66


may be retracted in a proximal direction as indicated by arrow


72


relative to the outer tubular member


64


to cause the balloon


68


to further invert thereby shortening the overall length of the balloon


68


. By shortening the length of the balloon


68


, the interior


70


of the balloon


68


correspondingly decreases in length such that the radioactive fluid disposed in the interior


70


of the balloon


68


as a reduced length L


2


. With this arrangement, longitudinal displacement of the inner member


66


relative to the outer member


64


may be used to control the length of the radiation source (i.e., the radioactive fluid disposed in the interior


70


of the balloon


68


. Inner tubular member


66


is longitudinally movable relative to the outer tubular member


64


.




Catheter


60


may be used substantially the same as catheter


40


, except that longitudinal displacement of the inner tubular member


66


causes variation of length of the radiation source.




Refer now to

FIGS. 8A and 8B

which illustrate longitudinal cross-sectional views of the present invention in the form of a catheter


80


having means for advancing and retracting radioactive seeds


88


of variable number. Except as described herein, catheter


80


is similar to other embodiments of the present invention previously described. Catheter


80


represents a generic catheter for advancing and retracting radioactive seeds. Specific embodiments of such a catheter may be found in U.S. Pat. No. 5,683,345 to Waksman et al. and U.S. patent application Ser. No. 08/866,560 now U.S. Pat. No. 6,019,718 to Hektner et al., the disclosures of which are hereby incorporated by reference. Waksman et al. disclose a device wherein the radioactive seeds are advanced and retracted pneumatically. Hektner et al. disclose a catheter wherein the radioactive seeds are advanced and retracted mechanically as with a string or cable. Although illustrated as utilizing pneumatic means, catheter


80


is illustrated in generic form and may readily utilize either pneumatic or mechanical means to advance and retract the radioactive seeds. In addition, in light of these disclosures, only the distal portion of the catheter


80


has been illustrated for purposes of clarity and simplicity.




Catheter


80


includes an elongate shaft having a delivery lumen


84


and a return lumen


86


. Delivery lumen


84


is sized to accommodate radioactive seeds


88


such that the seeds may be readily transported pneumatically from the proximal end of the shaft


82


to the distal end of the shaft


82


. Return lumen


86


is sized to provide a fluid path such that the distal end of the delivery lumen


84


may be pressurized causing the radioactive seeds


88


to return to the proximal end of the elongate shaft


82


. The proximal end of the elongate shaft


82


may be connected to an after-loader (not shown) which incorporates a means to vary the number of radioactive seeds


88


delivered to the distal end of the catheter


80


.




Such means may comprise, for example, a cartridge containing the maximum number of seeds


88


usable with the catheter


80


from which the physician may select the desired number seeds


88


. The desired number of seeds


88


may be automatically or manually loaded into the delivery lumen


84


. For example, to select the desired number, a pin may be placed in a slot in the cartridge behind a row seeds


88


totaling the desired number. The pin may then be advanced in the slot thereby pushing the desired number of seeds


88


into the proximal end of the delivery lumen


84


. Alternatively, by using a spring loaded cartridge, seeds


88


may be individually advanced into the proximal end of the delivery lumen until reaching the desired number. Those skilled in the art will recognize that many different cartridge designs may be employed in addition to other similarly functioning designs to vary the number of radioactive seeds


88


. Adaptable designs are disclosed in U.S. Pat. No. 5,860,909 to Mick and U.S. Pat. No. 5,342,283 to Good, both of which are hereby incorporated by reference.




By changing the number of radioactive seeds


88


delivered to the distal end of the catheter


80


, the effective length of the radioactive source may be changed. As illustrated in

FIG. 8A

, catheter


80


has several radioactive seeds


88


disposed in the distal end of the shaft


82


to define a relatively long radioactive section having a length L


1


. As shown in

FIG. 8B

, fewer radioactive seeds


88


are disposed in the distal end of the elongate shaft


82


to define a relatively short radioactive section having a length L


2


wherein L


2


is less than L


1


. Accordingly, by utilizing the means for varying the number of radioactive seeds to be delivered through the delivery lumen


84


, the overall length of the radiation source may be varied.




Refer now to

FIGS. 9A and 9B

which illustrate longitudinal cross-sectional views of the present invention in the form of a catheter


90


having means for advancing and retracting radioactive seeds of variable spacing. Except as described herein, catheter


90


is substantially the same in form and function as catheter


80


.




Catheter


90


includes an elongate shaft


82


having a delivery lumen


84


and a return lumen


86


. The plurality of radioactive seeds are disposed in the distal end of the delivery lumen


84


. Non-radioactive spacers


92


are disposed between each of the radioactive seeds


88


. Non-radioactive spacers


92


may comprise any inert material.




The proximal end of the catheter


90


may be connected to an after loader containing a means for varying the number of spacers


92


disposed between the radioactive seeds


88


. The means for varying the number of spacers


92


may be substantially the same as the means for varying the number of radioactive seeds as described with reference to catheter


80


.




As illustrated in

FIG. 9A

, catheter


90


includes several spacers


92


disposed between the radioactive seeds


88


to define a radiation source having a relatively long length L


1


.

FIG. 9B

illustrates fewer spacers


92


disposed between adjacent radioactive seeds


88


to define a radiation source having a relatively short length L


2


, wherein L


2


is less than L


1


. With this arrangement, the overall length of the radiation source as defined by the length of the radioactive seeds


88


and spacers


92


may be varied by varying the number of spacers disposed between adjacent seeds


88


.




Catheters


80


and


90


may be used substantially the same as described by Waksman et al. except that the number of radioactive seeds


88


and/or the number of spacers disposed between adjacent radioactive seeds may be varied to vary the length of the radioactive source.




From the foregoing, it should be apparent that the present invention provides a variable-length radiation source to compensate for any mismatch in length that would otherwise occur between a fixed-length radiation source and the treatment site. Thus, the variable-length radiation source of the present invention provides a means to match the radiation source length to the length of the treatment site, thus mitigating against overexposure and underexposure. In addition, the variable-length design of the present invention reduces the inventory that must be kept on hand to treat different patients with different treatment site lengths, thereby reducing the otherwise significant cost of storing radioactive material.




Those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.



Claims
  • 1. A medical device for intravascular ionizing radiation therapy, comprising:an elongate shaft having a proximal end and a distal end, the elongate shaft including an inner member and an outer member wherein the inner member is longitudinally movable relative to the outer member; and a variable-length ionizing radiation source disposed on the distal end of the shaft, wherein a proxinal end of the radiation source is connected to a distal end of the outer member, and a distal end of the radiation source is connected to a distal end of the inner member.
  • 2. A medical device as in claim 1, wherein the radiation source comprises an extendable tip including a radioactive material.
  • 3. A medical device as in claim 2, wherein the extendable tip is a coil.
  • 4. A medical device as in claim 1, wherein longitudinal displacement of the inner member relative to the outer member causes corresponding longitudinal displacement of the distal end of the radiation source.
  • 5. A medical device as in claim 4, wherein the longitudinal displacement of the distal end of the radiation source causes length variation of the radiation source.
  • 6. A medical device as in claim 5, wherein the inner member includes a stop disposed on a proximal end thereof to limit length variation of the radiation source.
  • 7. A medical device as in claim 5, wherein the radiation source comprises a extendable tip.
  • 8. A medical device as in claim 5, wherein the radiation source comprises an inverting balloon.
  • 9. A medical device for intravascular ionizing radiation therapy, comprising:an elongate shaft having a proximal end and a distal end; an ionizing radiation source comprising a variable-length tip disposed on the distal end of the shaft; and means for varying the length of the radiation source, wherein the means for varying the length of the radiation source comprises a movable member connected to an end of the variable-length tip.
  • 10. A method of delivering ionizing radiation to a treatment site inside a patient's vasculature, comprising the steps of:providing a medical device including an elongate shaft having a variable-length ionizing radiation source comprising a variable-length lip disposed on a distal end of the shaft and a means for varying the length of the radiation source, wherein the means for varying the length of the radiation source comprises a movable member connected to an end of the vanable-length tip; inserting the medical device into the vasculature of the patient; changing the length of the radiation source; and removing the medical device from the vasculature of the patient.
  • 11. A method as in claim 10, wherein the step of changing the radioactive length is performed prior to the step of inserting the medical device into the vasculature of the patient.
  • 12. A method as in claim 10, wherein the step of changing the radioactive length is performed after to the step of inserting the medical device into the vasculature of the patient.
US Referenced Citations (158)
Number Name Date Kind
2546761 Loftus Mar 1951 A
2862108 Meilink Nov 1958 A
2955208 Stevens Oct 1960 A
3060924 Rush Oct 1962 A
3147383 Prest Sep 1964 A
3324847 Zoumbolis Jun 1967 A
3505991 Hellerstein et al. Apr 1970 A
3643096 Jeffries, Jr. et al. Feb 1972 A
3669093 Sauerwein et al. Jun 1972 A
3674006 Holmer Jul 1972 A
3750653 Simon Aug 1973 A
3811426 Culver et al. May 1974 A
3861380 Chassagne et al. Jan 1975 A
3866050 Whitfield Feb 1975 A
3927325 Hungate et al. Dec 1975 A
4096862 DeLuca Jun 1978 A
4220864 Sauerwein et al. Sep 1980 A
4225790 Parson, Jr. et al. Sep 1980 A
4233517 Van't Hooft Nov 1980 A
4244357 Morrison Jan 1981 A
4281252 Parsons, Jr. et al. Jul 1981 A
4314157 Gaines Feb 1982 A
4364376 Bigham Dec 1982 A
4584991 Tokita et al. Apr 1986 A
4588395 Lemelson May 1986 A
4631415 Sauerwein et al. Dec 1986 A
4702228 Russell, Jr. et al. Oct 1987 A
4706652 Horowitz Nov 1987 A
4763642 Horowitz Aug 1988 A
4763671 Goffinet Aug 1988 A
4782834 Maguire et al. Nov 1988 A
4784116 Russell, Jr. et al. Nov 1988 A
4815449 Horowitz Mar 1989 A
4819618 Liprie Apr 1989 A
4851694 Rague et al. Jul 1989 A
4861520 van't Hooft et al. Aug 1989 A
4881937 van't Hooft et al. Nov 1989 A
4897076 Puthawala et al. Jan 1990 A
4936823 Colvin et al. Jun 1990 A
4963128 Daniel et al. Oct 1990 A
4969863 van't Hooft et al. Nov 1990 A
4976266 Huffman et al. Dec 1990 A
4976680 Hayman et al. Dec 1990 A
4976690 Solar et al. Dec 1990 A
5030194 Van't Hooft Jul 1991 A
5032113 Burns Jul 1991 A
5059166 Fischell et al. Oct 1991 A
5084001 Van't Hooft et al. Jan 1992 A
5084002 Liprie Jan 1992 A
5092834 Ishiwara et al. Mar 1992 A
5120973 Rohe et al. Jun 1992 A
5139473 Bradshaw et al. Aug 1992 A
5141487 Liprie Aug 1992 A
5147282 Kan Sep 1992 A
5163896 Suthanthiran et al. Nov 1992 A
5176617 Fischell et al. Jan 1993 A
5183455 Hayman et al. Feb 1993 A
5199939 Dake et al. Apr 1993 A
5213561 Weinstein et al. May 1993 A
5261879 Brill Nov 1993 A
5267960 Hayman et al. Dec 1993 A
5282781 Liprie Feb 1994 A
5302168 Hess Apr 1994 A
5344383 Liping Sep 1994 A
5354257 Roubin et al. Oct 1994 A
5370685 Stevens Dec 1994 A
5391139 Edmundson Feb 1995 A
5395300 Liprie Mar 1995 A
5405309 Carden, Jr. Apr 1995 A
5409015 Palermo Apr 1995 A
5411466 Hess May 1995 A
5425720 Rogalsky et al. Jun 1995 A
5429582 Williams Jul 1995 A
5484384 Fearnot Jan 1996 A
5498227 Mawad Mar 1996 A
5503613 Weinberger Apr 1996 A
5503614 Liprie Apr 1996 A
5532122 Drukier Jul 1996 A
5538494 Matsuda Jul 1996 A
5540659 Teirstein Jul 1996 A
5556389 Liprie Sep 1996 A
5575749 Liprie Nov 1996 A
5575771 Walinsky Nov 1996 A
5605530 Fischell et al. Feb 1997 A
5611767 Williams Mar 1997 A
5616114 Thornton et al. Apr 1997 A
5618266 Liprie Apr 1997 A
5624372 Liprie Apr 1997 A
5643171 Bradshaw et al. Jul 1997 A
5649924 Everett et al. Jul 1997 A
5653683 D'Andrea Aug 1997 A
5662580 Bradshaw et al. Sep 1997 A
5674177 Hehrlein et al. Oct 1997 A
5683345 Waksman et al. Nov 1997 A
5688220 Verin et al. Nov 1997 A
5707332 Weinberger Jan 1998 A
5713828 Coniglione Feb 1998 A
5720717 D'Andrea Feb 1998 A
5722984 Fischell et al. Mar 1998 A
5728042 Schwager Mar 1998 A
5730698 Fischell et al. Mar 1998 A
5776099 Tremulis Jul 1998 A
5782740 Schneiderman Jul 1998 A
5782742 Crocker et al. Jul 1998 A
5795286 Fischell et al. Aug 1998 A
5800333 Liprie Sep 1998 A
5803895 Kronholz et al. Sep 1998 A
5807231 Liprie Sep 1998 A
5816259 Rose Oct 1998 A
5816999 Bischoff et al. Oct 1998 A
5820553 Hughes Oct 1998 A
5833593 Liprie Nov 1998 A
5840008 Klein et al. Nov 1998 A
5840009 Fischell et al. Nov 1998 A
5840064 Liprie Nov 1998 A
5843163 Wall Dec 1998 A
5851171 Gasson Dec 1998 A
5851172 Bueche et al. Dec 1998 A
5855546 Coletti Jan 1999 A
5857956 Liprie Jan 1999 A
5863284 Klein Jan 1999 A
5863285 Hastings et al. Feb 1999 A
5865720 Hastings et al. Feb 1999 A
5871436 Eury Feb 1999 A
5871437 Alt Feb 1999 A
5873811 Wang et al. Feb 1999 A
5879282 Fischell et al. Mar 1999 A
5882290 Kume Mar 1999 A
5882291 Bradshaw et al. Mar 1999 A
5891091 Teirstein Apr 1999 A
5897573 Rosenthal et al. Apr 1999 A
5899882 Waksman et al. May 1999 A
5906573 Aretz May 1999 A
5910101 Andrews et al. Jun 1999 A
5910102 Hastings Jun 1999 A
5913813 Williams et al. Jun 1999 A
5916143 Apple et al. Jun 1999 A
5919126 Armini Jul 1999 A
5924973 Weinberger Jul 1999 A
5924974 Loffler Jul 1999 A
5938582 Ciamacco, Jr. et al. Aug 1999 A
5947899 Hehrlein Sep 1999 A
5947924 Liprie Sep 1999 A
5947958 Woodard et al. Sep 1999 A
5957829 Thornton Sep 1999 A
5961439 Chernomorsky et al. Oct 1999 A
5967966 Kornholz et al. Oct 1999 A
5971909 Bradshaw et al. Oct 1999 A
5976106 Verin et al. Nov 1999 A
5997462 Loffler Dec 1999 A
5997463 Cutter Dec 1999 A
6010445 Armini et al. Jan 2000 A
6013019 Fischell et al. Jan 2000 A
6013020 Meloul et al. Jan 2000 A
6024690 Lee et al. Feb 2000 A
6030333 Sioshansi et al. Feb 2000 A
6033357 Ciezki et al. Mar 2000 A
6149574 Trauthen et al. Nov 2000 A
Foreign Referenced Citations (112)
Number Date Country
2166915 Aug 1996 CA
91 02 312.2 Aug 1992 DE
195 26 680 Jan 1997 DE
197 54 870 Aug 1998 DE
197 24 233 Dec 1998 DE
197 58 234 Jul 1999 DE
198 07 727 Jul 1999 DE
198 25 563 Dec 1999 DE
198 25 999 Dec 1999 DE
198 26 000 Dec 1999 DE
198 29 447 Jan 2000 DE
0 360 582 Aug 1990 EP
0 514 913 Nov 1992 EP
0 633 041 Jan 1995 EP
0 686 342 Dec 1995 EP
0 688 580 Dec 1995 EP
0 696 906 Feb 1996 EP
0 749 764 Dec 1996 EP
0 754 472 Jan 1997 EP
0 754 473 Jan 1997 EP
0 593 136 Mar 1997 EP
0 788 051 Jun 1997 EP
0 801 961 Oct 1997 EP
0 810 004 Dec 1997 EP
0 813 894 Dec 1997 EP
0 629 380 Jul 1998 EP
0 865 803 Sep 1998 EP
0 904 798 Mar 1999 EP
10071210 Mar 1998 JP
WO 8603124 Jun 1986 WO
WO 9304735 Mar 1993 WO
WO 9425106 Nov 1994 WO
WO 9426205 Nov 1994 WO
WO 9507732 Mar 1995 WO
WO 9606654 Mar 1996 WO
WO 9610436 Apr 1996 WO
WO 9613303 May 1996 WO
WO 9614898 May 1996 WO
WO 9617654 Jun 1996 WO
WO 9622121 Jul 1996 WO
WO 9629943 Oct 1996 WO
WO 9640352 Dec 1996 WO
WO 9707740 Mar 1997 WO
WO 9709937 Mar 1997 WO
WO 9717029 May 1997 WO
WO 9718012 May 1997 WO
WO 9719706 Jun 1997 WO
WO 9725102 Jul 1997 WO
WO 9725103 Jul 1997 WO
WO 9740889 Nov 1997 WO
WO 9801183 Jan 1998 WO
WO 9801184 Jan 1998 WO
WO 9801185 Jan 1998 WO
WO 9801186 Jan 1998 WO
WO 9811936 Mar 1998 WO
WO 9816151 Apr 1998 WO
WO 9820935 May 1998 WO
WO 9825674 Jun 1998 WO
WO 9824049 Jul 1998 WO
WO 9830273 Jul 1998 WO
WO 9834681 Aug 1998 WO
WO 9836788 Aug 1998 WO
WO 9836790 Aug 1998 WO
WO 9836796 Aug 1998 WO
WO 9839052 Sep 1998 WO
WO 9839062 Sep 1998 WO
WO 9839063 Sep 1998 WO
WO 9840032 Sep 1998 WO
WO 9846309 Oct 1998 WO
WO 9855179 Dec 1998 WO
WO 9857706 Dec 1998 WO
WO 9901179 Jan 1999 WO
WO 9902219 Jan 1999 WO
WO 9904706 Feb 1999 WO
WO 9904856 Feb 1999 WO
WO 9910045 Mar 1999 WO
WO 9921615 May 1999 WO
WO 9921616 May 1999 WO
WO 9922774 May 1999 WO
WO 9922775 May 1999 WO
WO 9922812 May 1999 WO
WO 9922815 May 1999 WO
WO 9924116 May 1999 WO
WO 9924117 May 1999 WO
WO 9929354 Jun 1999 WO
WO 9929370 Jun 1999 WO
WO 9929371 Jun 1999 WO
WO 9930779 Jun 1999 WO
WO 9934969 Jul 1999 WO
WO 9936121 Jul 1999 WO
WO 9939628 Aug 1999 WO
WO 9940962 Aug 1999 WO
WO 9940970 Aug 1999 WO
WO 9940971 Aug 1999 WO
WO 9940972 Aug 1999 WO
WO 9940973 Aug 1999 WO
WO 9940974 Aug 1999 WO
WO 9942162 Aug 1999 WO
WO 9942163 Aug 1999 WO
WO 9942177 Aug 1999 WO
WO 9944686 Sep 1999 WO
WO 9944687 Sep 1999 WO
WO 9949935 Oct 1999 WO
WO 9956825 Nov 1999 WO
WO 9956828 Nov 1999 WO
WO 9961107 Dec 1999 WO
WO 9962598 Dec 1999 WO
WO 9966979 Dec 1999 WO
WO 0003292 Jan 2000 WO
WO 0004838 Feb 2000 WO
WO 0004953 Feb 2000 WO
WO 0009212 Feb 2000 WO
Non-Patent Literature Citations (6)
Entry
Tjho-Heslinga et al., “Results of ruthenium irradiation of uveal melanona”, Radiothereapy Oncology, vol. 29, pp 33-38, Dec. 1993.
Lommatzsch et al., “Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques”, Graefe's Arch. Clin. Exp. Opthalmology vol. 232, pp. 482-487, Dec. 1994.
Radiotherapy of Intraoculare and Orbital Tumors, Springer-Verlak publishers, Berlin Heidelberg and New York, copyright Dec. 1993, pp. 23-30 and 363-367.
Fackelmann, “Harbinger of a Heart Attack”, Science News, vol. 151, Jun. 14, 1997, pp. 374-375.
Raloff, “Nuclear Medicine Gets Friendlier—Experimental Therapies Seek to Poison Just the Disease”, Science News, vol. 152, Jul. 19, 1997, pp. 40-41.
Sutherland, “Managing Cancer Through Synergy”, Administrative Radiology Journal, Nov. 1996, pp. 21-27.